The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity - PubMed (original) (raw)
The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity
G Schett et al. Lupus. 2002.
Abstract
This study investigates specificity, sensitivity and concomitant presence of antibodies against histone H1 (H1), nucleosomes (NUC), chromatin (CHR) and dsDNA in patients with systemic lupus erythematosus (SLE), analyses their association with SLE disease activity and characterizes the immunodominant epitope reactivity of anti-H1 antibodies and its relation to SLE disease activity. In a cross-sectional study 394 sera of patients with various rheumatic diseases and healthy subjects were analysed by ELISA for antibodies against H1, NUC, CHR and dsDNA. In addition, a longitudinal analysis was performed that included 121 sequential serum samples derived from 16 SLE patients to assess the relation of these antibodies as well as antibodies to histone H2B to SLE disease activity. To assess epitope reactivity of anti-H1 antibodies overlapping synthetic peptides covering the entire H1 sequence were used. Anti-H1 antibodies yielded a sensitivity of approximately 45% and a specificity of over 98% for SLE, which was comparable to that found for anti-dsDNA antibodies. Anti-CHR and anti-NUC antibodies were of similar sensitivity but slightly (anti-CHR) or considerably (anti-NUC) less specific for SLE (95 and 85%, respectively). The sequential analysis revealed a strong correlation of anti-H1 antibodies with SLE disease activity that was better than the correlation of anti-dsDNA and anti-NUC antibodies, while only weak correlation was found for anti-CHR and anti-H2B antibodies. The immunodominant epitope for anti-HI was localised between amino acids 204 and 218 (pp204-218) and immune reactivity to this epitope also correlated with disease activity. Anti-H1 is a highly specific marker for SLE with a diagnostic value comparable to anti-dsDNA. A positive testing for anti-H1 indicates increased disease activity, as does the appearance of antibodies to its immunodominant epitope pp204-218.
Similar articles
- Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD, Patwardhan MM, Ghosh K. Pradhan VD, et al. Indian J Dermatol Venereol Leprol. 2010 Mar-Apr;76(2):145-9. doi: 10.4103/0378-6323.60558. Indian J Dermatol Venereol Leprol. 2010. PMID: 20228543 - Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients.
Touloupi E, Routsias JG, Tzioufas AG. Touloupi E, et al. Clin Exp Immunol. 2005 Oct;142(1):172-9. doi: 10.1111/j.1365-2249.2005.02892.x. Clin Exp Immunol. 2005. PMID: 16178873 Free PMC article. - Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus.
González C, Garcia-Berrocal B, Herráez O, Navajo JA, González-Buitrago JM. González C, et al. Clin Chem Lab Med. 2004 Mar;42(3):266-72. doi: 10.1515/CCLM.2004.049. Clin Chem Lab Med. 2004. PMID: 15080558 - Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
Bizzaro N, Villalta D, Giavarina D, Tozzoli R. Bizzaro N, et al. Autoimmun Rev. 2012 Dec;12(2):97-106. doi: 10.1016/j.autrev.2012.07.002. Epub 2012 Jul 15. Autoimmun Rev. 2012. PMID: 22810055 Review. - Anti-chromatin (anti-nucleosome) antibodies.
Gómez-Puerta JA, Burlingame RW, Cervera R. Gómez-Puerta JA, et al. Lupus. 2006;15(7):408-11. doi: 10.1191/0961203306lu2325oa. Lupus. 2006. PMID: 16898174 Review.
Cited by
- Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus.
Shabana AA, El-Ghawet AE, Machaly SA, Abu Hashim EM, El-Kady BA, Shaat R. Shabana AA, et al. Clin Rheumatol. 2009 Jun;28(6):673-8. doi: 10.1007/s10067-009-1130-2. Epub 2009 Mar 14. Clin Rheumatol. 2009. PMID: 19291351 - Antinucleosome in systemic lupus erythematosus. A study in a Brazilian population.
Sardeto GA, Simas LM, Skare TS, Nisihara RM, Utiyama SR. Sardeto GA, et al. Clin Rheumatol. 2012 Mar;31(3):553-6. doi: 10.1007/s10067-011-1889-9. Epub 2011 Nov 18. Clin Rheumatol. 2012. PMID: 22089161 - Systemic lupus erythematosus patients contain significantly less igm against mono-methylated lysine than healthy subjects.
Guo S, Liu Y, Ma Y, Zhao Q, Zhu L, Shao Y, Gao F, Wu F, Gao R, Zhang W. Guo S, et al. PLoS One. 2013 Jul 16;8(7):e68520. doi: 10.1371/journal.pone.0068520. Print 2013. PLoS One. 2013. PMID: 23874652 Free PMC article. - Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus.
Li T, Prokopec SD, Morrison S, Lou W, Reich H, Gladman D, Urowitz M, Scholey J, Fortin PR, Boutros PC, Wither J, Landolt-Marticorena C. Li T, et al. Rheumatology (Oxford). 2015 Mar;54(3):449-57. doi: 10.1093/rheumatology/keu326. Epub 2014 Sep 5. Rheumatology (Oxford). 2015. PMID: 25193804 Free PMC article. - Autoantibody-dependent amplification of inflammation in SLE.
Lou H, Wojciak-Stothard B, Ruseva MM, Cook HT, Kelleher P, Pickering MC, Mongkolsapaya J, Screaton GR, Xu XN. Lou H, et al. Cell Death Dis. 2020 Sep 9;11(9):729. doi: 10.1038/s41419-020-02928-6. Cell Death Dis. 2020. PMID: 32908129 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous